In a strategic move to ramp up its global market presence, SUANNUTRA, a key player in the nutraceutical sector, has appointed Anthony Weston as its new CEO.
Part of SUANFARMA, a global life science company, SUANNUTRA is committed to delivering innovative and high-quality nutraceutical products to consumers. Weston, with his extensive global business management and leadership experience, is expected to drive the company’s customer-centric initiatives and global expansion plans.
Weston’s appointment reflects SUANNUTRA’s determination to consolidate its position in the global nutraceutical market by leveraging its core brands such as Gonmisol, Monteloeder, and Suanfarma USA.
Francisco Fernández, who continues to lead SUANFARMA and will serve as a key advisor to SUANNUTRA, expressed confidence in Anthony Weston’s abilities and highlighted his inspiring leadership and strategic vision.
With a global presence across 50 countries, SUANNUTRA is well-positioned to drive innovation and offer a broad range of science-backed nutraceutical products. The company is committed to meeting the dynamic demands of global consumers through a strong and recognizable global presence.